n-acetylaspartic acid has been researched along with Cancer of Prostate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Knedlik, T; Konvalinka, J; Tykvart, J; Vorlova, B | 1 |
Baek, HM; Choi, C; Ding, Y; Ganji, SK; Geethanath, S; Kodibagkar, VD; Lewis, MA; Maher, EA; Sims, RD | 1 |
1 review(s) available for n-acetylaspartic acid and Cancer of Prostate
Article | Year |
---|---|
GCPII and its close homolog GCPIII: from a neuropeptidase to a cancer marker and beyond.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antigens, Surface; Aspartic Acid; Biomarkers, Tumor; Brain; Carboxypeptidases; Disease Models, Animal; Glutamate Carboxypeptidase II; Glutamates; Humans; Hydrolysis; Inflammatory Bowel Diseases; Intestine, Small; Jejunum; Male; Mice; Mice, Mutant Strains; Mice, Transgenic; Neuropeptides; Peptide Hydrolases; Phenotype; Prostatic Neoplasms; Rats | 2019 |
1 other study(ies) available for n-acetylaspartic acid and Cancer of Prostate
Article | Year |
---|---|
Compressive sensing could accelerate 1H MR metabolic imaging in the clinic.
Topics: Algorithms; Analysis of Variance; Aspartic Acid; Brain Neoplasms; Choline; Citric Acid; Creatine; Data Compression; Female; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Spectroscopy; Male; Prostatic Neoplasms; Retrospective Studies | 2012 |